Pfizer-BioNTech COVID-19 Vaccine was authorized for use in accordance with the
Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19. As an extraordinary measure to provide earlier access to vaccine supplies in the context of the global pandemic, Pfizer/BioNTech is providing, at this time, vaccine cartons and vials labelled with the US Emergency Use label. This label is presented in English-only and is missing some important Canadian-specific information normally found on Health Canada approved labels.
Products affected
Pfizer-BioNTech COVID-19 Vaccine, suspension for intramuscular injection, multiple dose vials. After dilution, the vial contains 5 doses (each dose is 0.3 mL).
DIN: 02509210
Manufacturer: BioNTech Manufacturing GmbH (Germany)
Canadian Importer and Distributor: Pfizer Canada ULC
Background information
Pfizer-BioNTech COVID-19 Vaccine is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.
Given the public health emergency resulting from the current pandemic, Health Canada has authorized the importation, sale, and advertising of Pfizer-BioNTech COVID-19 Vaccine with carton and vial labels that are in English-only and meant for the initial global distribution of the vaccine. This allows earlier access to the vaccine for the Canadian population ahead of the Canadian-labelled Pfizer-BioNTech COVID-19 Vaccine being available, and facilitates the global deployment of this vaccine across many countries given the high demand.
Pfizer-BioNTech COVID-19 Vaccine with global labels is the same as the Health Canada authorized Pfizer-BioNTech COVID-19 Vaccine in all aspects (i.e., formulation, strength, route of administration) and should be used in Canada for the same indication and per the same vaccination schedule. The Canadian Product Monograph for Pfizer-BioNTech COVID-19 Vaccine, which is approved by Health Canada and available in French and English, should be used for complete product information. The Product Monograph is available on Health Canada’s
Drug Product Database, on the government’s
covid-vaccine.canada.ca website, or at
pfizer.ca and
CVDvaccine.ca.
The use of Pfizer-BioNTech COVID-19 Vaccine is permitted under an interim authorization in accordance with the
Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.
Patients should be advised of the nature of the authorization.